WASHINGTON (Reuters) - New Jersey-based drugmaker Teva has agreed to pay $450 million to resolve allegations that it violated ...

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a wide economic moat. Growth of existing products and new product launches should help offset ...

Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources to create the next generation of healthcare treatments. The company's innovative new product lineup and ...

You were correct that there is a major change to the 2025 Medicare Part D plan. This change helps to make prescription drugs ...

Toni:I understand that there is a major change to the 2025 Medicare Part D plan with the “Donut Hole” going away. I’m concerned because this year, I entered the donut ...

New research contradicts promises of savings at the pharmacy counter for Medicare beneficiaries from the Inflation Reduction Act's (IRA) drug pricing provisions. In fact, the study suggests some ...

Biden-Harris Administration Takes Next Step on Proposed Model to Lower Prescription Drug Costs for People with Medicare ...

Toni: I understand that there is a major change to the 2025 Medicare Part D plan with the “Donut Hole” going away. I’m ...

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

Investigating America’s Drug Shortage Crisis,” a series exploring the causes and possible solutions of a problem plaguing ...

The Centers for Medicare & Medicaid Services Oct. 9 released a request for information and a sample list of prescription ...